Introducing a modern chemotherapeutic drug formulated by iron nanoparticles for the treatment of human lung cancer

Figures & data

Figure 1. UV–vis the spectrum of green synthesized FeNPs.

Figure 2. FT-IR spectra of Alhagi maurorum extract and green synthesized FeNPs.

Figure 3. XRD pattern of green synthesized FeNPs.

Figure 4. SEM images of FeNPs.

Figure 5. EDS analysis of FeNPs.

Figure 6. The anti-human lung cancer properties (cell viability (%)) of FeNPs (concentrations of 0–1000 µg/mL) against human lung cancer (NCI-N87 (I) and MKN45 (II)) and normal (HUVEC: III) cell lines.

Table 1. The IC₅₀ of FeNPs in the anti-human lung cancer test.

	HLC-1	PC-14	HUVEC
IC50 (µg/mL)	195	181	–

Figure 7. The antioxidant properties of FeNPs (I) and BHT (II) against DPPH.

Table 2. The IC₅₀ of FeNPs and BHT in the antioxidant test.

	FeNPs	BHT
IC50 (µg/mL)	214	62